...
首页> 外文期刊>Nanotechnology >Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations
【24h】

Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations

机译:蔗糖酯稳定的固体脂质纳米颗粒和纳米结构脂质载体:II。咪唑类抗真菌药物纳米粒分散体及其凝胶制剂的评价

获取原文
获取原文并翻译 | 示例
           

摘要

This study focused on: (i) feasibility of the previously developed sucrose ester stabilized SLNs and NLCs to encapsulate different imidazole antifungal drugs and (ii) preparation and evaluation of topical gel formulations of those SLNs and NLCs. Three imidazole antifungal drugs; clotrimazole, ketoconazole and climbazole were selected for this study. The results suggested that size, size distribution and drug encapsulation efficiency depend on the drug molecule and type of nanoparticles (SLN/NLC). The drug release experiment always showed faster drug release from NLCs than SLNs when the same drug molecule was loaded in both nanoparticles. However, drug release rate from both SLNs and NLCs followed the order of climbazole > ketoconazole > clotrimazole. NLCs demonstrated better physicochemical stability than SLNs in the case of all drugs. The drug release rate from ketoconazole- and clotrimazole-loaded SLNs became faster after three months than a fresh formulation. There was no significant change in drug release rate from climbazole-loaded SLNs and all drug-loaded NLCs. Gel formulations of SLNs and NLCs were prepared using polycarbophil polymer. Continuous flow measurements demonstrated non-Newtonian flow with shear-thinning behavior and thixotropy. Oscillation measurements depicted viscoelasticity of the gel formulations. Similar to nanoparticle dispersion, drug release rate from SLN- and NLC-gel was in the order of climbazole > ketoconazole > clotrimazole. However, significantly slower drug release was noticed from all gel formulations than their nanoparticle counterparts. Unlike nanoparticle dispersions, no significant difference in drug release from gel formulations containing SLNs and NLCs was observed for each drug. This study concludes that gel formulation of imidazole drug-loaded SLNs and NLCs can be used for sustained/prolonged topical delivery of the drugs.
机译:这项研究的重点是:(i)先前开发的蔗糖酯稳定的SLN和NLC封装不同咪唑类抗真菌药的可行性,以及(ii)这些SLN和NLC的局部凝胶制剂的制备和评估。三种咪唑类抗真菌药;本研究选择了克霉唑,酮康唑和克霉唑。结果表明,大小,大小分布和药物封装效率取决于药物分子和纳米颗粒(SLN / NLC)的类型。药物释放实验始终显示,当两个纳米颗粒中均装载相同的药物分子时,从NLC中释放的药物要比SLN更快。但是,SLNs和NLCs的药物释放速率均遵循以下条件:攀登唑>酮康唑>克霉唑。在所有药物中,NLCs均比SLNs表现出更好的理化稳定性。三个月后,从装载有酮康唑和克霉唑的SLN中释放出来的药物的速度比新鲜制剂要快。装载了坎吡唑的SLN和所有装载了NLC的药物的释放速率没有显着变化。 SLN和NLC的凝胶配方是使用聚卡波非聚合物制备的。连续流量测量表明非牛顿流具有剪切稀化行为和触变性。振荡测量描述了凝胶制剂的粘弹性。与纳米颗粒分散体相似,从SLN-和NLC-凝胶释放的药物的顺序为:攀登唑>酮康唑>克霉唑。然而,从所有凝胶制剂中观察到的药物释放均比其纳米颗粒对应物慢得多。与纳米颗粒分散体不同,对于每种药物,从包含SLN和NLC的凝胶制剂中释放的药物没有观察到显着差异。这项研究得出的结论是,咪唑类药物负载的SLN和NLC的凝胶制剂可用于持续/延长药物的局部递送。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号